December 1, 1996
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Structured PICO
Does carvedilol added to standard therapy reduce clinical progression in patients with mildly symptomatic, well-compensated heart failure?
P
Population
Patients who are only mildly symptomatic with well-compensated heart failure
I
Intervention
Carvedilol added to standard therapy, including an ACE inhibitor
C
Comparator
Standard therapy, including an ACE inhibitor
O
Outcome
Clinical progression
Carvedilol added to standard therapy including an ACE inhibitor is effective at reducing clinical progression in patients with mildly symptomatic heart failure.
Abstract
Carvedilol, when added to standard therapy, including an ACE inhibitor, reduces clinical progression in patients who are only mildly symptomatic with well-compensated heart failure.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
Wilson S. Colucci
Heart Failure & Transplant
Milton Packer
Heart Failure & Transplant
Michael R. Bristow
Heart Failure & Transplant
Journals
Circulation
Actions
Institutions
GlaxoSmithKline (Netherlands)
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...